February 11, 2021
The challenge of diagnosis occurs in distinguishing “normal” from “abnormal” in a time of rapid and dynamic change.
October 01, 2020
A secondary analysis of the Women’s Health Initiative (WHI)-Calcium and Vitamin D (CaD) clinical trial has concluded that vasomotor symptom severity is not linked to any clinical event.
August 10, 2020
A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.
July 20, 2020
Read about the impact when long-acting reversible contraception (LARC) was offered to teenage mothers prior to hospital discharge.
July 10, 2020
A peak in hot fl ash reports was observed in July, while January had a trough in hot fl ash reports.
July 09, 2020
The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”
June 22, 2020
New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).
June 10, 2020
Australian researchers believe that PD-L1 may have potential as an indicator of potential response to chemotherapy in women with metastatic breast cancer. That was based on results of a randomized trial, presented at the European Society for Medical Oncology in Lugano, Switzerland.
May 21, 2020
Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.
May 12, 2020
The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.